Published in Hepatitis Weekly, October 23rd, 2006
Study 1: Recent research from Japan has reported on the identification of defective hepatitis C virus (HCV) clones in liver transplant recipients with recurrent HCV infection.
"Patients with recurrent hepatitis C after liver transplantation usually have a high viral load and are generally resistant to interferon (IFN)-alpha 2b plus ribavirin (RBV) therapy. However, it remains unclear whether pretreatment viral titer determines the effectiveness of combination therapy, especially in patients with a high viral load.
"The aim...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-10-23)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.